Effects of Neoadjuvant Immunotherapy on Anti-tumour Immunity in Hepatocellular Carcinoma Patients Undergoing Liver Resection

Clinical trial NCT07461675 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07461675
Sponsor: University of Geneva, Switzerland
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Hepato Cellular Carcinoma (HCC)Immunotherapy

Start date: 2026-03-25
Primary completion: 2029-06-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.